Serum syndecan‐1 levels were increased in RA patients and decreased following a 6 week‐anti‐inflammatory treatment with methotrexate or tumor necrosis factor (TNF)‐α inhibitors [75]. The gene discussed is TNF; the disease is rheumatoid arthritis.